Shenzhen YHLO Biotech Co Ltd (shse:688575) Share Price

Company Profile

Business description
Shenzhen YHLO Biotech Co Ltd is engaged in the research, development, production and sales of in vitro diagnostic instruments and supporting reagents based on chemiluminescence immunoassay. Its product portfolio includes solutions based on technologies such as chemiluminescence, biochemistry, indirect immunofluorescence, immunoblotting, fluorescent immunochromatography, and colloidal gold immunochromatography. Its products are used in diagnostic applications including autoimmunity, reproductive health, infection, liver disease, and respiratory disease testing, and are supplied to healthcare institutions and testing centers.
Contact
Baolong 2nd Road, Baolong Street
Building 1, Yahuilong Biotechnology Factory Area
Longgang District
Guangdong Province
Shenzhen518116
CHN
T: +86 75584821649
https://www.szyhlo.com
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
1,664

Recommended

Has the market overlooked this ASX tech share?

Roy Van Keulen | 22 June 2026

Impact of tariffs have been priced in.

Angus Hewitt, CFA | 22 June 2026

SpaceX has risen 50% from its IPO price to become the second-most-expensive stock under Morningstar’s coverage.

Tom Lauricella | 19 June 2026

Index	Last price	Change	% Change
All Ordinaries	9,031.20	9.40	0.10%
CAC 40	8,398.48	22.66	-0.27%
DAX 40	25,105.44	119.62	0.48%
Dow JONES (US)	51,711.30	146.60	0.28%
FTSE 100	10,425.40	62.13	0.60%
HKSE	23,768.52	156.29	-0.65%
NASDAQ	26,242.59	275.34	-1.04%
Nikkei 225	72,353.96	1,103.90	1.55%
NZX 50 Index	13,446.05	49.58	-0.37%
S&P 500	7,477.67	22.91	-0.31%
S&P/ASX 200	8,816.10	14.20	0.16%
SSE Composite Index	4,163.10	72.62	1.78%